Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 979645, 10 pages
http://dx.doi.org/10.1155/2015/979645

Research Article

The Effects of Age and Latent Cytomegalovirus Infection on NK-Cell Phenotype and Exercise Responsiveness in Man

Austin B. Bigley, Guillaume Spielmann, Nadia Agha, and Richard J. Simpson

Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston, 3855 Holman Street, Houston, TX 77204, USA

Received 6 March 2015; Revised 27 May 2015; Accepted 3 June 2015

Academic Editor: Gareth Davison

Copyright © 2015 Austin B. Bigley et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The redeployment of NK-cells in response to an acute bout of exercise is thought to be an integral component of the “fight-or-flight” response, preparing the body for potential injury or infection. We showed previously that CMV seropositivity impairs the redeployment of NK-cells with exercise in the young. In the current study, we examined the effect of aging on the redeployment of NK-cells with exercise in the context of CMV. We show here that CMV blunts the exercise-induced redeployment of NK-cells in both younger (23–39 yrs) and older (50–64 yrs) subjects with older subjects showing the largest postexercise mobilization and 1 h postexercise egress of NK-cells. The blunted exercise response in individuals was associated with a decreased relative redeployment of the CD158a+ and CD57+ NK-cell subsets in younger and older individuals. In addition, we show that aging is associated with a CMV-independent increase in the proportion of NK-cells expressing the terminal differentiation marker CD57, while CMV is associated with an age-dependent decrease in the proportion of NK-cells expressing the inhibitory receptors KLRG1 (in the younger group) and CD158a (in the older group). Collectively, these data suggest that CMV may decrease NK-cell mediated immunosurveillance after exercise in both younger and older individuals.

1. Introduction

The rapid redeployment of NK-cells between the tissues and the peripheral circulation is an archetypal feature of the acute stress response. The response can be evoked using acute bouts of dynamic exercise [1, 2], laboratory-based psychological stress tasks [3], or beta-agonist (i.e., epinephrine) infusion [4] and is often considered to be an accurate representation of an organism’s ability to mount an effective immune response during fight-or-flight scenarios when tissue injury and infection are likely to occur. Acute exercise is associated with increased plasma levels of stress hormones including the catecholamines epinephrine and norepinephrine [5], which interact with β-adrenergic receptors (β-AR) on the surface of lymphocytes. NK-cells express more β-AR than other lymphocytes [6] and, as a result, they are the most responsive lymphocyte subset to exercise [7, 8] and catecholamines [4, 9].

Cytomegalovirus (CMV) is a prevalent beta herpesvirus infecting 50–80% of the US population [10, 11]. We have shown that prior exposure to CMV profoundly impacts the redistribution of lymphocytes to an acute exercise bout. While those with CMV have an augmented redeployment of CD8+ T-cells [12, 13] and γδ T-cells [14], NK-cell mobilization is dramatically impaired [15]. This blunted NK-cell response appears to be attributable to a CMV-induced accumulation of specific NK-cell subsets that have a lower expression of β2-AR and an impaired ability to produce cyclic AMP in response to in vitro stimulation with the β-agonist isoproterenol [16]. Moreover, those with CMV fail to exhibit exercise-induced enhancements in NK-cell function, indicating that CMV may compromise NK-cell mediated immunosurveillance after an acute bout of strenuous exercise [16].

In addition to infection history, aging is known to have a profound impact on the cellular response to acute stress and exercise [17]; however, studies investigating the effects of aging on NK-cell exercise responsiveness are lacking [18]. While aging has been reported to have no effect on NK-cell mobilization with exercise [19, 20], it is known to increase the proportion of CD56dim/KIR+/CD57+ NK-cells [19, 21, 22], a subset we have previously shown to be preferentially mobilized by exercise [23]. In addition, several of the phenotypic hallmarks of aging overlap with those associated with latent CMV infection in the young including upregulation of CD57 [19, 24, 25] and downregulation of KLRG1 [15, 26]. Despite CMV prevalence increasing with age [11], previous studies have compared NK-cell responses between young and old exercisers without accounting for this confounding variable [19, 20]. We showed recently that CMV was associated with enhanced redeployment of CD8+ T-cells regardless of age [13], while, conversely, aging impairs the redeployment of γδ T-cells independently of CMV [14]. However, no study to our knowledge has compared NK-cell responses to a single bout of exercise between different age groups while controlling for CMV serostatus. Given that CMV prevalence increases with age and many of the effects of CMV mirror those attributable to aging, it is important to resolve the effects of age and CMV infection on the frequency and exercise responsiveness of distinct NK-cell subsets.

The aim of this study was to determine if latent CMV infection blunts the redeployment of NK-cells to a single exercise bout in older individuals as it does in the young [15] and to delineate the effects of age and CMV on the redeployment of discrete NK-cell subsets. We show here that CMV has a potent blunting effect on exercise-induced NK-cell mobilization in both younger (23–39 yrs) and older (50–64 yrs) subjects with the greatest mobilization being seen in the older group. This blunting effect of CMV was most pronounced with the CD158a+ and CD57+ NK-cell subsets regardless of age.

2. Materials and Methods

2.1. Participants

40 healthy adult males (age: 23–64 years) participated in this study. The exclusion criteria of this study required that participants avoid smoking, medication/supplements, or infection within 6 weeks of the experiment. Oral and written information regarding the risks and requirements of the study were provided, after which each participant signed an informed consent affidavit. Protocol approval was granted by CPHS at the University of Houston. Participant attributes and exercise data are provided in Table 1.

Table 1: Physical characteristics of the participants ( = 20; = 20). Data are mean ± SD. CMV seronegative and CMV seropositive participants indicated by − and +, respectively. Statistical differences between younger (23–39 yrs) and older (50–64 yrs) subjects are indicated by # < 0.05. CMV serostatus did not affect any of the physical characteristics ( > 0.05).

Characteristics
Younger (−)
[ = 12]
Younger (+)
[ = 12]
Older (−)
[ = 8]
Older (+)
[ = 8]
One-way ANOVA
statistic ( value)

CMV
Age

Age (years)
30.8 ± 6.4
30.0 ± 6.0
55.6 ± 3.6#
57.1 ± 4.1#
<0.1 (0.88)
163.1 (<0.001)

Height (cm)
179.4 ± 7.1
177.9 ± 5.4
178.2 ± 8.6
177.2 ± 6.3
1.3 (0.26)
0.1 (0.72)

Mass (kg)
81.2 ± 12.8
82.8 ± 12.1
79.6 ± 8.1
79.8 ± 10.2
<0.1 (0.98)
<0.1 (0.84)

BMI (kg⋅m⁻²)
25.1 ± 3.2
25.7 ± 4.7
24.8 ± 2.1
25.8 ± 2.7
0.5 (0.45)
<0.1 (0.90)

Maximum power (W)
241.3 ± 76.5
226.2 ± 57.0
235.7 ± 65.6
225.8 ± 38.8
0.4 (0.53)
<0.1 (0.88)

O2max (mL⋅kg⁻¹⋅min⁻¹)
39.6 ± 13.0
36.7 ± 6.3
40.7 ± 17.4
40.3 ± 7.5
0.4 (0.49)
<0.1 (0.90)

Maximum heart rate (bpm)
187.7 ± 6.1
187.8 ± 5.8
164.4 ± 3.6
164.9 ± 3.7
<0.1 (0.87)
163.4 (<0.001)

Physical activity ratinga (0–7)
5.0 ± 2.2
5.4 ± 2.1
6.3 ± 1.0
5.6 ± 1.9
<0.1 (0.90)
3.2 (0.09)

Age-adjusted fitness scoreb (1–5)
3.6 ± 1.8
3.1 ± 1.1
4.1 ± 1.2
3.7 ± 1.0
<0.1 (0.83)
2.2 (0.14)

Exercise measures

Mean power (W)
183.6 ± 63.5
175.8 ± 61.1
181.3 ± 38.5
172.4 ± 29.7
0.2 (0.62)
<0.1 (0.87)

Mean power (% max)
76.3 ± 11.9
77.5 ± 13.8
77.9 ± 6.2
76.7 ± 7.0
<0.1 (0.99)
<0.1 (0.92)

Mean Heart rate (bpm)
158.7 ± 10.3
159.6 ± 7.5
151.0 ± 7.8#
147.5 ± 8.1#
0.2 (0.64)
13.1 (0.001)

Mean heart rate (% max)
85.4 ± 5.4
84.5 ± 2.7
91.7 ± 4.9#
89.1 ± 3.7#
1.8 (0.20)
14.6 (<0.001)

Maximum heart rate estimated by the equation: 191.5 − (0.007 × age²) [27].

aPhysical Activity Rating (PA-R) calculated from Jackson Questionnaire [28].

bAge-adjusted Fitness Score calculated from Adams and Beam equations [29].

2.2. Exercise Protocols and Blood Sampling

Maximal oxygen uptake ( max) was estimated using the Astrand [30] submaximal cycling exercise protocol as previously described [15]. The Adams and Beam equations [29] were used to estimate the max and maximum power of each participant.

Participants reported to the lab following an overnight fast within 2 weeks (minimum: 2 days) of the submaximal max test to complete a 30 min cycling protocol. A resting intravenous blood sample was collected in 6 mL Vacutainers containing either EDTA or serum gel (BD, Franklin Lakes, NJ, USA) prior to exercise. Participants then cycled for 30 min at 80% of max power and peripheral blood samples were collected again immediately after and 1 h after exercise. Serum was frozen at −80°C until analysis (in duplicate) for CMV IgG antibodies using commercially available ELISA kits (BioCheck, Foster City, CA, USA) and a 96-well microplate reader (Molecular Devices, Sunnyvale, CA, USA).

2.3. Flow Cytometry

PBMCs were separated from whole blood using Histopaque per the manufacturer’s instructions (Sigma-Aldrich, St. Louis, MO, USA). Aliquots of isolated cells were incubated for 30 minutes with 50 μL of prediluted APC-conjugated anti-CD3, Alexa488-conjugated anti-KLRG1 [31] or FITC-conjugated anti-CD56, PerCP-Cy5.5-conjugated anti-CD8 or PerCP-eFluor710-conjugated anti-CD56, and PE-conjugated anti-CD57 or anti-CD158a monoclonal antibodies. All of the antibodies were purchased from eBioscience (San Diego, CA, USA) except for the anti-KLRG1 antibody that was generously provided by Dr. Hanspeter Pircher. Lymphocyte phenotype and cell count were assessed by 4-color flow cytometry using an Accuri C6 flow cytometer (Accuri, Ann Arbor, MI, USA) as previously described [15].

2.4. Statistical Analysis

SPSS version 22 (Chicago, IL, USA) was used for all statistical analyses. The effects of CMV and age on NK-cell phenotype, participant attributes, and exercise data were determined using a separate restricted maximum likelihood linear mixed model (LMM) including main effects for CMV serostatus and age, as well as an interaction term for CMV serostatus age. To determine the effects of CMV and age on the acute exercise response of NK-cell subsets, a LMM was built that included main effects for CMV serostatus, age, and exercise (before, after, and 1 h after), as well as interaction terms for CMV serostatus exercise and age exercise. The precise location of significant main effects was determined using Bonferroni post-hoc analysis. Independent sample -tests were used to compare delta values (i.e., cells mobilized and egressed by exercise) relative to CMV serostatus and age. Statistical significance was assessed at .

3. Results

3.1. Age and CMV Have Distinct Effects on NK-Cell Phenotype

To determine the effects of age and CMV on NK-cell subsets, we evaluated NK-cell phenotype in the context of age and latent CMV infection (Figure 1). Aging increases the proportion of CD57+ NK-cells [ = 6.551, ] and decreases the proportion of CD56-bright NK-cells [ = 5.363, ]. The effects of age on CD57+ and CD56-bright NK-cells were CMV independent [ = 0.37, and = 0.022, , resp.]. While there was no overall effect of age on NK-cell CD158a expression [ = 2.581, ], there was an interaction effect between CMV and age [ = 3.91, ]. The proportion of CD158a+ NK-cells was lower in the older (50–64 yrs) group (). While there was no main effect of age on NK-cell KLRG1 [ = 0.154, ] or CD8 expression [ = 1.904, ], the proportion of KLRG1+ NK-cells was greater in the younger (23–39 yrs) group () and the proportion of CD8+ NK-cells was greater in the older group ().

Figure 1: The effects of latent CMV infection and age on the proportion of total NK-cells (% of lymphocytes) and NK-cell subsets (% of NK-cells). Values are mean ± SE. Significance is connoted by .

3.2. Latent CMV Infection Impairs the Exercise-Induced Mobilization of NK-Cells in Both Younger and Older Adults

The effects of age and CMV serostatus on the exercise response of total NK-cells and NK-cell subsets are shown in Table 2. The number of total NK-cells and all NK-cell subsets was increased immediately after exercise compared to baseline and 1 h after exercise (). There was a main effect of CMV serostatus on total NK-cell number [ = 5.652, ] that was independent of age [ = 1.323, ]. The main effect of CMV serostatus was the result of fewer NK-cells immediately after exercise (). There was no main effect of age on total NK-cell number [ = 2.617, ]; however, the postexercise NK-cell count was greater in older relative to younger subjects ().

Table 2: Exercise-induced changes in NK-cell subset numbers in healthy adult males ( = 20; = 20) contrasted by CMV serostatus and age. CMVpos and CMVneg participants are denoted by + and −, respectively. Main and interaction effects for CMV, age, and time are reported with significance connoted by ( < 0.05). Statistical differences from pre- and 1 h post-values are described by # and ∧, respectively ( < 0.05). Data are mean ± SD.

NK-Cell subsets
CMV status
Pre-values
Post-values
1 h post-values
Main effects
statistic ( value)
Interactions
statistic ( value)

Time
Age
CMV
Time × Age
Time × CMV
Age × CMV
Time × Age × CMV

Total NK-cells/L

#∧
#
157.7 (<0.001)
2.6 (0.108)
5.7 (0.019)
0.6 (0.557)
4.7 (0.019)
1.3 (0.252)
1.0 (0.357)

Younger
(23–39 yrs)
−
166 ± 96
785 ± 337
130 ± 117

+
181 ± 97
595 ± 360
128 ± 84

Older
(50–64 yrs)
−
223 ± 56
987 ± 182
142 ± 57

+
189 ± 85
666 ± 242
153 ± 69

CD56dim (cells/L)

#∧
#
157.1 (<0.001)
2.8 (0.085)
5.6 (0.020)
0.7 (0.518)
4.7 (0.018)
1.7 (0.197)
1.1 (0.333)

Younger
(23–39 yrs)
−
147 ± 91
738 ± 325
106 ± 100

+
162 ± 94
556 ± 357
112 ± 82

Older
(50–64 yrs)
−
205 ± 58
942 ± 184
125 ± 57

+
176 ± 79
631 ± 217
135 ± 54

CD56 bright (cells/L)

#∧

25.2 (<0.001)
1.1 (0.291)
2.5 (0.114)
<0.1 (0.999)
0.4 (0.687)
<0.1 (0.834)
0.5 (0.636)

Younger
(23–39 yrs)
−
19 ± 12
47 ± 27
24 ± 22

+
19 ± 9
39 ± 15
16 ± 7

Older
(50–64 yrs)
−
18 ± 9
45 ± 23
17 ± 6

+
13 ± 10
35 ± 31
18 ± 15

KLRG1+ (cells/L)

#∧

72.6 (<0.001)
0.1 (0.773)
2.1 (0.153)
0.1 (0.929)
1.1 (0.335)
0.1 (0.788)
0.1 (0.948)

Younger
(23–39 yrs)
−
98 ± 76
493 ± 240
80 ± 73

+
84 ± 70
334 ± 284
56 ± 64

Older
(50–64 yrs)
−
111 ± 45
481 ± 149
78 ± 13

+
95 ± 64
398 ± 198
69 ± 44

CD57+ (cells/L)

#∧

98.5 (<0.001)
5.3 (0.023)
5.2 (0.024)
1.7 (0.196)
2.5 (0.084)
2.7 (0.105)
1.0 (0.360)

Younger
(23–39 yrs)
−
63 ± 39
335 ± 190
53 ± 49

+
74 ± 48
310 ± 184
50 ± 32

Older
(50–64 yrs)
−
125 ± 29
578 ± 146
87 ± 29

+
110 ± 46
453 ± 109
80 ± 29

CD158a+ (cells/L)

#∧

50.7 (<0.001)
0.9 (0.349)
2.7 (0.103)
0.3 (0.717)
1.3 (0.284)
0.2 (0.698)
<0.1 (0.980)

Younger
(23–39 yrs)
−
40 ± 25
228 ± 191
31 ± 34

+
40 ± 20
179 ± 87
28 ± 19

Older
(50-64 yrs)
−
51 ± 37
277 ± 91
32 ± 28

+
25 ± 16
119 ± 97
17 ± 15

CD8+ (cells/L)

#∧

79.4 (<0.001)
8.4 (0.004)
1.2 (0.269)
2.7 (0.069)
1.7 (0.193)
4.8 (0.031)
3.0 (0.052)

Younger
(23–39 yrs)
−
51 ± 35
184 ± 126
45 ± 46

+
61 ± 37
210 ± 94
42 ± 28

Older
(50–64 yrs)
−
94 ± 36
406 ± 159
62 ± 21

+
62 ± 43
200 ± 75
39 ± 22

The exercise responsiveness of NK-cells based on CMV serostatus and age is described in Figure 2(a). CMV seropositivity was associated with a lower exercise-induced redeployment of NK-cells [ = 4.664, ] that was independent of age [ = 1.037, ]. Specifically, the mobilization and egress of NK-cells were greater in individuals regardless of age () as seen in Figure 2(b). Age did not affect the redeployment of NK-cells with exercise [ = 0.587, ].

(a)

(b)

(c)

Figure 2: Latent CMV infection impairs the exercise-induced mobilization of NK-cells in both younger and older adults. (a) shows the effect of exercise at 80% of estimated maximum power on NK-cell count based on latent CMV infection and age. (b) shows the effect of latent CMV infection and age on the mobilization and egress of NK-cells in response to an acute bout of exercise at 80% of estimated maximum power. Values are mean ± SE. Differences based on CMV serostatus and age are indicated by and , respectively. (c) displays representative flow cytometry dot-plots for the redeployment of NK-cells with exercise relative to CMV serostatus and age.

Aging was associated with an increased percentage of NK-cells within the lymphocyte pool [ = 5.123, ] that was dependent on CMV serostatus [ = 12.777, ]. Specifically, the proportion of NK-cells was elevated in older subjects that were () but not in those that were infected with CMV (). As with cell number, CMV seropositivity was associated with a lower proportional increase in NK-cells after exercise [ = 3.221, ] that was independent of age [ = 1.258, ]. Representative flow cytometry dot-plots illustrating the age-independent blunting of NK-cell exercise responsiveness in those infected with CMV are shown in Figure 2(c).

3.3. Latent CMV Infection Decreases the Exercise Responsiveness of CD57+ and CD158a+ NK-Cells Independently of Age

To assess the effects of age and CMV on the redeployment of NK-cell subsets with exercise, we evaluated exercise-induced changes in the proportion of NK-cell subsets in relation to age and latent CMV infection (Figure 3(a)). The proportion of CD57+ and CD158a+ NK-cells is increased immediately after exercise (). The exercise effects on NK-cell CD57 and CD158a expression were independent of CMV [ = 0.016, and = 0.075, , resp.] and age [ = 0.213, and = 0.312, , resp.]. The mobilization and egress of CD57+ and CD158a+ NK-cells were greater in CMV-seronegative subjects relative to those infected with CMV (). In addition, the proportion of CD56-bright NK-cells was increased 1 h after exercise () independently of CMV [ = 0.059, ] and age [ = 0.016, ]. Exercise had no effect on NK-cell KLRG1 or CD8 expression [ = 0.404, and = 0.018, , resp.]. In addition, CMV serostatus did not affect the mobilization or egress of CD56-bright, KLRG1+, or CD8+ NK-cells (). Representative flow cytometry dot-plots for the coexpression of KLRG1 and CD57 in relation to exercise are shown in Figure 3(b).

(a)

(b)

Figure 3: Latent CMV infection decreases the exercise responsiveness of CD57+ and CD158a+ NK-cells independently of age. (a) shows the effects of CMV and age on the redeployment of CD57+ and CD158a+ NK-cells in response to an acute bout of exercise at 80% of estimated maximum power. Values are mean ± SE. Differences based on CMV serostatus are connoted by . (b) displays representative flow cytometry dot-plots for the coexpression of KLRG1 and CD57 before and after exercise based on latent CMV infection and age.

4. Conclusions

This is the first study to examine the effects of aging and latent CMV infection on NK-cell redeployment in response to a single bout of intensity-controlled exercise. We report that latent CMV infection is associated with a blunted exercise-induced redeployment of NK-cells in both younger (23–39 yrs) and older (50–64 yrs) subjects with older subjects showing the greatest postexercise mobilization and 1 h postexercise egress of NK-cells. This blunted exercise response in individuals was associated with a decreased relative redeployment of the CD158a+ and CD57+ NK-cell subsets in both younger and older individuals. In addition, we show for the first time that the previously reported age-associated increase in the proportion of CD57+ NK-cells is independent of CMV, while the proportion of CD8+ NK-cells and the percentage of NK-cells in the lymphocyte pool are increased in older individuals only. Further, CMV is associated with an age-dependent decrease in the proportion of NK-cells expressing the inhibitory receptors KLRG1 (lower in younger ) and CD158a (lower in older ).

The redeployment of cytotoxic lymphocytes (including NK-cells) in response to an acute bout of exercise is thought to be an integral part of the “fight-or-flight” response, preparing the body for potential injury or infection [3]. We show here that CMV seropositivity is associated with a blunted redeployment of NK-cells in older subjects and that increased age is associated with a greater redeployment of NK-cells in individuals. This builds on our previous finding that latent CMV infection is associated with a blunted exercise-induced redeployment of NK-cells in the young [15]. Alternatively, it has been reported that the mobilization of CD8+ cytotoxic T-cells is greater in individuals [12] and we have shown that this CMV effect is particularly pronounced in the old [13]. Considering that there is no difference in lymphocyte mobilization between and individuals [12, 13], it appears that the effects of CMV on redeployment of cytotoxic CD8+ T-cells and NK-cells largely offset each other. Thus, it could be that postexercise immunosurveillance is tilted towards T-cell-mediated immunity in individuals and NK-cell mediated immunity in individuals with this contrast being most evident in older individuals. Given the decline in T-cell function with age [32] and the accumulation of senescent T-cells in those with CMV [33], this suggests a general decline in postexercise immunosurveillance in older individuals.

The redeployment of individual NK-cell subsets with exercise is nonuniform. We have previously reported that NK-cells expressing inhibitory KIR (such as CD158a) and the terminal differentiation marker CD57 are preferentially mobilized by exercise [23]. In the current study, we report that the mobilization of CD158a+ and CD57+ NK-cells with exercise is reduced in individuals regardless of age. We have shown earlier that CMV impairs NK-cell mobilization in response to high intensity exercise through downregulation of β2-AR expression on CD57+ NK-cells and impaired β-AR signaling in younger individuals [16]. This mechanism likely applies to older subjects as well given the similar impairment in CD57+ NK-cell exercise responsiveness between younger and older subjects. The decreased exercise-induced redeployment of CD57+ NK-cells in individuals is likely to have functional implications as CD57+ NK-cells have high cytotoxic functions, but greatly reduced proliferative capacity [34, 35]. Due to their high expression of differentiation markers [36] and their poor cytokine-driven proliferation, CD57+ NK-cells are considered to be terminally differentiated [34].

We show here that CMV and age combine to influence NK-cell phenotype in many interesting ways that have often been overlooked in the literature due to failure to recruit older individuals. For example, it has been reported in multiple studies that the proportion of CD57+ NK-cells is increased in the elderly [19, 37, 38]; however, it has been reported by Campos et al. that this aging effect is actually a CMV effect with subjects having a higher proportion of CD57+ NK-cells regardless of age [24]. The conclusions of Campos et al. are limited, however, by the lack of elderly in their cohort [24]. Our study includes older individuals and contradicts the findings of Campos et al. [24] as we show a CMV-independent increase in the proportion of CD57+ NK-cells with aging. These findings are consistent with the CMV-independent increase in the CD56dim : CD56 bright ratio with age shown here and elsewhere [21], which suggests that the accumulation of highly differentiated NK-cells is attributable to aging independently of latent CMV infection. The increased proportion of CD56dim CD57+ NK-cells in the older group likely contributes to the increased exercise-induced redeployment of NK-cells in older relative to younger individuals. One of the limitations of this study is that we did not measure CD16 expression on NK-cells. CD16 is a marker of NK-cell differentiation and it is functionally important as it plays a critical role in NK-cell mediated antibody-dependent cytotoxicity [39]. We were unable to include CD16 as a marker of differentiation because we were limited by the constraints of 4-color flow cytometry.

We report a CMV-dependent decrease in the proportion of CD158a+ NK-cells with age. There was no overall difference in the proportion of CD158a+ NK-cells between younger and older subjects; however, the proportion of CD158a+ NK-cells was decreased in older subjects. Multiple studies have reported no effect of aging on inhibitory KIR expression [38, 40, 41]; however, one study reported an increase in inhibitory KIR expression with age [22]. None of these earlier studies investigated the relationship between these aging effects and CMV infection. We also show that the proportion of KLRG1+ NK-cells is decreased in younger individuals, but there is no CMV effect in the older group and no overall aging effect either. Our current data contradict a previous report by Hayhoe et al. that aging is associated with a marked decrease in the proportion of KLRG1+ NK-cells [26]. The discrepancy between our findings and those of Hayhoe et al. [26] are likely due to different definitions of young and old between the two studies. Hayhoe et al. compared individuals older and younger than 60 years [26], while we compared individuals aged 23–39 years to individuals aged 50–64 years. In our study, we investigated aging in preelderly (less than 65 years old), otherwise healthy individuals (presymptomatic for any age-related diseases). Future studies should determine if our results regarding the effects of aging and CMV on NK-cell phenotype and exercise responsiveness apply to females and individuals over the age of 65 as well.

In addition, we show for the first time that the previously reported increase in NK-cell proportion with age [22, 24] is CMV-dependent. Specifically, the proportion of NK-cells in the peripheral lymphocyte pool is elevated in older subjects, but not older subjects with CMV. The proportion of CD8+ NK-cells is also elevated in older subjects only, which suggests a possible increase in NK-cell cytotoxicity as CD8 expression has been mechanistically linked to increased NK-cell activity [42]. On the other hand, we have reported increased baseline NK-cell activity and impaired functional responses to exercise in younger individuals [16]. Thus, future studies are needed to determine the combined effects of CMV and aging on NK-cell function before and after exercise.

In summary, latent CMV infection was associated with a marked reduction in the mobilization of NK-cells in response to exercise in both younger and older adult males with the greatest mobilization being seen in older subjects. We also show that age was associated with a CMV-independent increase in the proportion of terminally differentiated CD57+ NK-cells and that CMV was associated with an age-dependent decrease in the proportion of NK-cells expressing the inhibitory receptors KLRG1 (lower in younger group) and CD158a (lower in older group). We conclude that latent CMV infection may compromise NK-cell mediated immunosurveillance following an acute stress response in both younger and older males.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors thank Dr. Hanspeter Pircher for generously providing them with the Alexa488-conjugated anti-KLRG1 (clone 13F12F2) monoclonal antibody. This work was supported by NASA Grant NNX12AB48G to R. J. Simpson.

References

R. J. Shephard and P. N. Shek, “Effects of exercise and training on natural killer cell counts and cytolytic activity,” Sports Medicine, vol. 28, no. 3, pp. 177–195, 1999.

A. Crisafulli, F. Tocco, F. Melis, R. Milia, and A. Concu, “Natural killer cells responsiveness to physical exercise: a brief review,” Open Journal of Immunology, vol. 3, no. 4, pp. 190–200, 2013.

J. A. Bosch, G. G. Berntson, J. T. Cacioppo, and P. T. Marucha, “Differential mobilization of functionally distinct natural killer subsets during acute psychologic stress,” Psychosomatic Medicine, vol. 67, no. 3, pp. 366–375, 2005.

M. Schedlowski, W. Hosch, R. Oberbeck et al., “Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms,” The Journal of Immunology, vol. 156, no. 1, pp. 93–99, 1996.

J. E. Dimsdale and J. Moss, “Plasma catecholamines in stress and exercise,” Journal of the American Medical Association, vol. 243, no. 4, pp. 340–342, 1980.

L. J. H. van Tits, M. C. Michel, H. Grosse-Wilde et al., “Catecholamines increase lymphocyte beta2-adrenergic receptors via a beta2-adrenergic, spleen-dependent process,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 258, no. 1, pp. E191–E202, 1990.

M. Kappel, N. Tvede, H. Galbo et al., “Evidence that the effect of physical exercise on NK cell activity is mediated by epinephrine,” Journal of Applied Physiology, vol. 70, no. 6, pp. 2530–2534, 1991.

N. Tvede, M. Kappel, K. Klarhund et al., “Evidence that the effect of bicycle exercise on blood mononuclear cell proliferative responses and subsets is mediated by epinephrine,” International Journal of Sports Medicine, vol. 15, no. 2, pp. 100–104, 1994.

B. Crary, S. L. Hauser, M. Borysenko et al., “Epinephrine-induced changes in the distribution of lymphocyte subsets in peripheral blood of humans,” Journal of Immunology, vol. 131, no. 3, pp. 1178–1181, 1983.

S. L. Bate, S. C. Dollard, and M. J. Cannon, “Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004,” Clinical Infectious Diseases, vol. 50, no. 11, pp. 1439–1447, 2010.

S. C. Dollard, S. A. S. Staras, M. M. Amin, D. S. Schmid, and M. J. Cannon, “National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity,” Clinical and Vaccine Immunology, vol. 18, no. 11, pp. 1895–1899, 2011.

J. E. Turner, S. Aldred, O. C. Witard, M. T. Drayson, P. M. Moss, and J. A. Bosch, “Latent cytomegalovirus infection amplifies CD8 T-lymphocyte mobilisation and egress in response to exercise,” Brain, Behavior, and Immunity, vol. 24, no. 8, pp. 1362–1370, 2010.

G. Spielmann, C. M. Bollard, A. B. Bigley et al., “The effects of age and latent cytomegalovirus infection on the redeployment of CD8⁺ T cell subsets in response to acute exercise in humans,” Brain, Behavior, and Immunity, vol. 39, pp. 142–151, 2013.

M. Pistillo, A. B. Bigley, G. Spielmann et al., “The effects of age and viral serology on γδ T-cell numbers and exercise responsiveness in humans,” Cellular Immunology, vol. 284, no. 1-2, pp. 91–97, 2013.

A. B. Bigley, T. W. Lowder, G. Spielmann et al., “NK-cells have an impaired response to acute exercise and a lower expression of the inhibitory receptors KLRG1 and CD158a in humans with latent cytomegalovirus infection,” Brain, Behavior, and Immunity, vol. 26, no. 1, pp. 177–186, 2012.

A. B. Bigley, K. Rezvani, M. Pistillo et al., “Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. Part II. Impact of latent cytomegalovirus infection and catecholamine sensitivity,” Brain, Behavior, and Immunity, 2015.

A. C. Phillips, V. E. Burns, and J. M. Lord, “Stress and exercise: getting the balance right for aging immunity,” Exercise and Sport Sciences Reviews, vol. 35, no. 1, pp. 35–39, 2007.

D. A. Haaland, T. F. Sabljic, D. A. Baribeau, I. M. Mukovozov, and L. E. Hart, “Is regular exercise a friend or foe of the aging immune system? A systematic review,” Clinical Journal of Sport Medicine, vol. 18, no. 6, pp. 539–548, 2008.

R. J. Simpson, C. Cosgrove, L. A. Ingram et al., “Senescent T-lymphocytes are mobilised into the peripheral blood compartment in young and older humans after exhaustive exercise,” Brain, Behavior, and Immunity, vol. 22, no. 4, pp. 544–551, 2008.

J. A. Woods, J. K. Evans, B. W. Wolters, M. A. Ceddia, and E. McAuley, “Effects of maximal exercise on natural killer (NK) cell cytotoxicity and responsiveness to interferon-alpha in the young and old,” Journals of Gerontology—Series A: Biological Sciences and Medical Sciences, vol. 53, no. 6, pp. B430–B437, 1998.

S. Chidrawar, N. Khan, W. Wei et al., “Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals,” Clinical and Experimental Immunology, vol. 155, no. 3, pp. 423–432, 2009.

C. T. Lutz, M. B. Moore, S. Bradley, B. J. Shelton, and S. K. Lutgendorf, “Reciprocal age related change in natural killer cell receptors for MHC class I,” Mechanisms of Ageing and Development, vol. 126, no. 6-7, pp. 722–731, 2005.

A. B. Bigley, K. Rezvani, C. Chew et al., “Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells,” Brain, Behavior, and Immunity, vol. 39, pp. 160–171, 2014.

C. Campos, A. Pera, B. Sanchez-Correa et al., “Effect of age and CMV on NK cell subpopulations,” Experimental Gerontology, vol. 54, pp. 130–137, 2014.

S. Lopez-Vergès, J. M. Milush, B. S. Schwartz et al., “Expansion of a unique CD57⁺NKG2 natural killer cell subset during acute human cytomegalovirus infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 36, pp. 14725–14732, 2011.

R. P. G. Hayhoe, S. M. Henson, A. N. Akbar, and D. B. Palmer, “Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset,” Human Immunology, vol. 71, no. 7, pp. 676–681, 2010.

R. L. Gellish, B. R. Goslin, R. E. Olson, A. McDonald, G. D. Russi, and V. K. Moudgil, “Longitudinal modeling of the relationship between age and maximal heart rate,” Medicine and Science in Sports and Exercise, vol. 39, no. 5, pp. 822–829, 2007.

A. S. Jackson, S. N. Blair, M. T. Mahar, L. T. Wier, R. M. Ross, and J. E. Stuteville, “Prediction of functional aerobic capacity without exercise testing,” Medicine & Science in Sports & Exercise, vol. 22, no. 6, pp. 863–870, 1990.

G. M. Adams and W. C. Beam, Exercise Physiology: Laboratory Manual, McGraw-Hill, Boston, Mass, USA, 1998.

I. Astrand, “Aerobic work capacity in men and women with special reference to age,” Acta Physiologica Scandinavica, vol. 49, no. 1, pp. 1–92, 1960.

I. Marcolino, G. K. Przybylski, M. Koschella et al., “Frequent expression of the natural killer cell receptor KLRG1 in human cord blood T cells: Correlation with replicative history,” European Journal of Immunology, vol. 34, no. 10, pp. 2672–2680, 2004.

T. Fülöp, A. Larbi, and G. Pawelec, “Human T cell aging and the impact of persistent viral infections,” Frontiers in Immunology, vol. 4, article 271, Article ID Article 271, 2013.

G. Pawelec, E. Derhovanessian, A. Larbi, J. Strindhall, and A. Wikby, “Cytomegalovirus and human immunosenescence,” Reviews in Medical Virology, vol. 19, no. 1, pp. 47–56, 2009.

S. Lopez-Vergès, J. M. Milush, S. Pandey et al., “CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset,” Blood, vol. 116, no. 19, pp. 3865–3874, 2010.

N. K. Björkström, P. Riese, F. Heuts et al., “Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education,” Blood, vol. 116, no. 19, pp. 3853–3864, 2010.

V. Béziat, B. Descours, C. Parizot, P. Debré, and V. Vieillard, “NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs,” PLoS ONE, vol. 5, no. 8, Article ID e11966, 2010.

F. Borrego, M. C. Alonso, M. D. Galiani et al., “NK phenotypic markers and IL2 response in NK cells from elderly people,” Experimental Gerontology, vol. 34, no. 2, pp. 253–265, 1999.

M. Le Garff-Tavernier, V. Béziat, J. Decocq et al., “Human NK cells display major phenotypic and functional changes over the life span,” Aging Cell, vol. 9, no. 4, pp. 527–535, 2010.

B. Perussia, G. Trinchieri, A. Jackson et al., “The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies,” Journal of Immunology, vol. 133, no. 1, pp. 180–189, 1984.

A. Almeida-Oliveira, M. Smith-Carvalho, L. C. Porto et al., “Age-related changes in natural killer cell receptors from childhood through old age,” Human Immunology, vol. 72, no. 4, pp. 319–329, 2011.

I. Gayoso, B. Sanchez-Correa, C. Campos et al., “Immunosenescence of human natural killer cells,” Journal of Innate Immunity, vol. 3, no. 4, pp. 337–343, 2011.

E. G. Addison, J. North, I. Bakhsh et al., “Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity,” Immunology, vol. 116, no. 3, pp. 354–361, 2005.